Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain fog may signal psychosis risk, new study suggests

NCT ID NCT06539611

Knowledge-focused Sponsor: Centre Hospitalier Esquirol Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 125 young people (ages 15–30) who are at risk for developing psychosis. Researchers want to see if a person's own complaints about thinking and memory problems can help predict whether they will later develop full psychosis. Participants are assessed over 30 months using interviews and questionnaires. The goal is to better understand early warning signs, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 125 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Mar 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All youth help-seekers assessed by early intervention team meeting the inclusion criteria will be asked to participate to the study.

Ages

15 to 30 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female ; * Be aged between 15 and 30 ; * Being assessed by the eDIP (early intervention team "équipe de détection et d'intervention précoce") ; * Sufficient level of French to understand and express yourself orally and in writing; * For adults: Patients who have received informed information about the study and who have signed a consent to participate in the study; \- For minors: Patient who has received informed information about the study and who has signed, as well as the holders of parental authority the minor's consent to participate in the study. Exclusion Criteria: * Have already presented a First Psychotic Episode; * Previous diagnosis of schizophrenia, psychotic disorder or bipolar disorder; * Being on antipsychotic treatment at the time of inclusion ; * Known intellectual disability ; * Pregnant or breast-feeding woman; * Minors and adults under legal protection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for At-risk mental states are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

At-risk mental states

Contacts and locations

Locations

  • Mirvat B HAMDAN-DUMONT

    Limoges, 87025, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.